Total Payments
$1,961
2023 Payments
$56.74
Companies
20
Transactions
138
Medicare Patients
308
Medicare Billing
$28,238
Payment Breakdown by Category
Food & Beverage$1,961 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,961 | 138 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $897.48 | 75 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $149.76 | 12 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $106.49 | 8 | $0 (2019) |
| GENZYME CORPORATION | $100.09 | 1 | $0 (2021) |
| Paratek Pharmaceuticals, Inc. | $79.99 | 1 | $0 (2019) |
| Takeda Pharmaceuticals America, Inc. | $75.46 | 7 | $0 (2017) |
| GlaxoSmithKline, LLC. | $75.14 | 6 | $0 (2019) |
| Medtronic USA, Inc. | $69.13 | 1 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $58.96 | 4 | $0 (2018) |
| Lilly USA, LLC | $44.16 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $56.74 | 3 | Novo Nordisk Inc ($56.74) |
| 2022 | $71.82 | 3 | ABBVIE INC. ($29.91) |
| 2021 | $100.09 | 1 | GENZYME CORPORATION ($100.09) |
| 2020 | $214.38 | 20 | Novo Nordisk Inc ($200.84) |
| 2019 | $450.77 | 28 | Novo Nordisk Inc ($215.22) |
| 2018 | $822.74 | 63 | Novo Nordisk Inc ($358.33) |
| 2017 | $244.23 | 20 | Takeda Pharmaceuticals America, Inc. ($75.46) |
All Payment Transactions
138 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/18/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $20.15 | General |
| 06/13/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $20.78 | General |
| 05/02/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.81 | General |
| 10/12/2022 | Horizon Therapeutics plc | PENNSAID (Drug) | Food and Beverage | Cash or cash equivalent | $19.97 | General |
| Category: PENNSAID | ||||||
| 08/29/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $21.94 | General |
| 01/25/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $29.91 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2021 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $100.09 | General |
| 12/03/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $10.43 | General |
| Category: Diabetes | ||||||
| 11/30/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $5.90 | General |
| Category: Diabetes | ||||||
| 11/11/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: Diabetes | ||||||
| 11/11/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $1.66 | General |
| Category: Diabetes | ||||||
| 10/23/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $5.43 | General |
| Category: Diabetes | ||||||
| 10/12/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: Diabetes | ||||||
| 09/29/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: Diabetes | ||||||
| 09/29/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $0.85 | General |
| Category: Diabetes | ||||||
| 08/21/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $5.43 | General |
| Category: Diabetes | ||||||
| 08/17/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: Diabetes | ||||||
| 08/07/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $5.14 | General |
| Category: Diabetes | ||||||
| 08/05/2020 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $10.78 | General |
| Category: Obesity | ||||||
| 08/05/2020 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $0.58 | General |
| Category: Obesity | ||||||
| 07/24/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: Diabetes | ||||||
| 02/21/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 02/17/2020 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: Diabetes | ||||||
| 02/17/2020 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $0.93 | General |
| Category: Diabetes | ||||||
| 02/14/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $6.27 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 4 | 166 | 216 | $48,561 | $17,029 |
| 2020 | 2 | 142 | 228 | $35,376 | $11,208 |
Total Patients
308
Total Services
444
Medicare Billing
$28,238
Procedure Codes
6
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 77 | 119 | $24,693 | $7,567 | 30.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Facility | 2021 | 31 | 31 | $12,090 | $5,026 | 41.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2021 | 18 | 18 | $4,770 | $2,295 | 48.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 40 | 48 | $7,008 | $2,141 | 30.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 79 | 144 | $25,632 | $8,329 | 32.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 63 | 84 | $9,744 | $2,879 | 29.5% |
About Dr. David Hess, M.D
Dr. David Hess, M.D is a Pediatrics healthcare provider based in Glen Dale, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2005. The National Provider Identifier (NPI) number assigned to this provider is 1477540748.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Hess, M.D has received a total of $1,961 in payments from pharmaceutical and medical device companies, with $56.74 received in 2023. These payments were reported across 138 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,961).
As a Medicare-enrolled provider, Hess has provided services to 308 Medicare beneficiaries, totaling 444 services with total Medicare billing of $28,238. Data is available for 2 years (2020–2021), covering 6 distinct procedure/service records.
Ad
Practice Information
- Specialty Pediatrics
- Other Specialties Internal Medicine
- Location Glen Dale, WV
- Active Since 10/03/2005
- Last Updated 04/06/2022
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1477540748
Products in Payments
- Ozempic (Drug) $438.65
- Victoza (Drug) $204.20
- Trintellix (Drug) $147.89
- XARELTO (Drug) $93.64
- NUZYRA (Drug) $79.99
- Tresiba (Drug) $77.56
- Amitiza (Drug) $77.33
- KYPHON Balloon Kyphoplasty (Device) $69.13
- ANORO (Drug) $47.94
- TRULICITY (Drug) $44.16
- Saxenda (Drug) $44.15
- BYSTOLIC (Drug) $43.01
- JANUVIA (Drug) $41.44
- Xultophy 100/3.6 (Drug) $40.80
- FARXIGA (Drug) $37.29
- ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH (Drug) $33.79
- Infinity DBS Pulse Generators (Device) $30.64
- UBRELVY (Drug) $29.91
- PENNSAID (Drug) $19.97
- STIOLTO (Drug) $17.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.